Tartrate-resistant acid phosphatase

From WikiMD's Medical Encyclopedia

Revision as of 23:41, 11 December 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Tartrate-resistant acid phosphatase

Tartrate-resistant acid phosphatase (TRAP) is an enzyme that is expressed in various tissues and is involved in several physiological and pathological processes. It is a member of the acid phosphatase family and is characterized by its resistance to inhibition by tartrate, a property that distinguishes it from other acid phosphatases.

Structure and Function[edit]

TRAP is a glycoprotein enzyme that contains a binuclear iron center, which is essential for its catalytic activity. The enzyme is expressed in several isoforms, with TRAP 5a and TRAP 5b being the most studied. TRAP 5b is particularly important in bone metabolism, as it is secreted by osteoclasts, the cells responsible for bone resorption.

TRAP plays a role in the degradation of bone matrix by osteoclasts, contributing to the release of minerals and the breakdown of organic components. It is also involved in the regulation of macrophage function and has been implicated in the immune response.

Clinical Significance[edit]

Elevated levels of TRAP, particularly TRAP 5b, are associated with increased osteoclastic activity and bone resorption. This makes TRAP a useful biomarker in the diagnosis and monitoring of bone-related diseases such as osteoporosis, Paget's disease of bone, and certain types of bone cancer.

In addition to its role in bone metabolism, TRAP has been studied in the context of autoimmune diseases and inflammatory diseases, where it may contribute to the pathogenesis of these conditions.

Diagnostic Use[edit]

TRAP activity can be measured in serum or plasma samples, and its levels are often assessed in conjunction with other markers of bone turnover. The measurement of TRAP 5b is particularly useful in evaluating the effectiveness of treatments for bone diseases, as it reflects changes in osteoclast activity.

Research and Future Directions[edit]

Ongoing research is exploring the potential of TRAP as a therapeutic target in diseases characterized by excessive bone resorption. Inhibitors of TRAP activity are being investigated for their ability to reduce bone loss and improve bone density in conditions such as osteoporosis.

Also see[edit]


Stub icon
   This article is a enzyme-related stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Start your transformation today with W8MD weight loss centers.

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.